影响植入物失败的因素的评估:一项为期13年的回顾性队列研究
Rabia Tül Adeviye Çankaya1, Mehtap Muğlalı1
1Ondokuz Mayıs University, Faculty of Dentistry, Department of Oral and Maxillofacial Surgery, Samsun, Turkey.
概括
这项研究确定了牙科康复中早期植入失败 (EIF) 和晚期植入失败 (LIF) 的独特风险因素. 了解这些因素,包括吸烟和植入物长度,对于改善患者的治疗结果和降低失败率至关重要.
科学领域:
- 口腔和牙面部外科手术
- 生物材料科学 生物材料科学
- 牙科植入物学 牙科植入物学
背景情况:
- 牙植入物失败在口腔康复中构成了重大挑战.
- 根据各种因素区分早期植入失败 (EIF) 和晚期植入失败 (LIF) 需要进一步调查.
研究的目的:
- 评估与EIF和LIF相关的风险因素.
- 确定与患者相关的,植入物特定的和手术变量的对牙植入物存活率的影响.
主要方法:
- 在2011年1月至2024年1月期间接受治疗的490名患者的回顾性队列研究.
- 分析患者的人口统计,吸烟习惯,植入物特征 (长度,表面) 和手术程序 (鼻腔提升).
主要成果:
- 对于EIF的风险因素包括性别,吸烟和植入物长度 (≤10毫米).
- 对LIF的危险因素包括部位置,更短的植入物长度 (<8毫米),SLA表面,鼻提升,吸烟和短时间的骨质整合时间.
- 针对EIF和LIF,确定了不同的风险概况.
结论:
- 患者选择,手术技术和植入物特征对于优化长期牙科植入物成功至关重要.
- 识别特定的EIF和LIF风险因素可以改进治疗方案,以改善患者的治疗结果.
相关概念视频
Factors Affecting Drug Response: Overview
3.1K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.1K
Factors Affecting Drug Distribution: Miscellaneous Factors
1.4K
Drug distribution in the human body is a complex process influenced by various individual factors, including age, pregnancy, obesity, diet, body water composition, pH levels, and specific disease conditions.
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
1.4K
Drug Product Performance: In Vitro–In Vivo Correlation
441
In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while...
441
Drug Product Stability
376
The long-term stability of drug products is critical to ensuring their quality, safety, and effectiveness over time. Stability directly influences a product's ability to maintain its intended characteristics, ensuring it performs as expected during its intended shelf life. Key attributes such as drug potency, impurities, dissolution, and other physicochemical measures of performance are tested to assess stability. These parameters indicate how well the product retains its quality over time and...
376
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
532
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
532
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
429
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
429


